Program at a Glance

  • Molecular Mechanism of HCC
  • Intermediatestage HCC (TKI, Lenvatinib, Regorafenib, Ramucirumab, etc.
  • Pathology of HCC
  • Oncoimmunotherapy for HCC
  • Surgery and Transplantation
  • HCC in Asia, Epidemiology
  • Management of HCC and Complications during TKI treatment
  • HCC after SVR
  • Molecular Mechanism of HCC
  • HAIC, TACE, RFA, Radiation
  • COVID-19 in Japan
  • Diagnosis of HCC
  • President Lecture
  • etc.
  • * Further information will be announced as soon as possible.